A correlation of endocrine and anticancer effects of some antagonists of GHRH

Peptides
Magdolna KovácsMarta Zarandi

Abstract

GHRH receptor antagonists inhibit growth and metastasis of a large number of experimental tumors expressing the pituitary GHRH receptor (pGHRH-R) and its major splice variant SV1. In this study, using Western blot, we demonstrated that DBTRG-05 and U-87MG human glioblastoma cell lines express pGHRH-R at levels 6-15 times higher than SV1. To reveal a correlation between the anticancer activity and the endocrine potency on inhibition of GH release, we compared the antitumor effect of GHRH antagonists JV-1-63 and MZJ-7-138 on growth of DBTRG-05 human glioblastomas grafted into athymic nude mice with their inhibitory potency on GH release. JV-1-63 strongly suppressed the stimulated GH secretion induced by clonidine in rats and inhibited the exogenous GHRH-induced GH surge by 88-99% in vivo and in vitro. MZJ-7-138 decreased the stimulated GH secretion by 58% in vitro and showed only a tendency to inhibit GH secretion in vivo. The strong inhibitor of GH release JV-1-63 reduced tumor growth of DBTRG-05 glioblastomas in nude mice by 46%, while the weak GH release suppressor MZJ-7-138 did not have an effect. Exposure of DBTRG-05 cells to the GHRH antagonists in vitro caused an upregulation of mRNA expression for pGHRH-R and a downregula...Continue Reading

References

Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·H KiarisJ L Varga
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·G HalmosT Czompoly
Aug 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·Z RekasiG Halmos
Aug 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Rebeca BustoKaroly Szepeshazi
Oct 5, 2002·The Journal of Clinical Endocrinology and Metabolism·Gabor HalmosZoltan Rekasi
Jan 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Markus LetschJozsef L Varga
May 28, 2003·Cancer Letters·Derek LeRoith, Charles T Roberts
Jul 18, 2003·Proceedings of the National Academy of Sciences of the United States of America·Hippokratis KiarisAnastasios Kalofoutis
Dec 9, 2003·Proceedings of the National Academy of Sciences of the United States of America·Celia A KanashiroJozsef L Varga
Feb 3, 2004·Proceedings of the National Academy of Sciences of the United States of America·Jozsef L VargaMarta Zarandi
Sep 2, 2004·European Journal of Endocrinology·Paul J Jenkins, Stephen A Bustin
Nov 22, 2005·Proceedings of the National Academy of Sciences of the United States of America·Alexandre HavtCelia A Kanashiro
Aug 15, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Solveig SchulzStefan Schulz
Mar 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·Nektarios BarabutisHippokratis Kiaris
Jul 11, 2007·Molecular Cancer Therapeutics·Antonio M P OmuroEric Raymond
Feb 22, 2008·Current Medicinal Chemistry·Magdolna KovácsMárta Zarándi
Feb 18, 2010·International Journal of Cancer. Journal International Du Cancer·Eva PozsgaiSzabolcs Bellyei

❮ Previous
Next ❯

Citations

Jan 8, 2014·Proceedings of the National Academy of Sciences of the United States of America·Cale D FahrenholtzKerry L Burnstein
Dec 17, 2015·Endocrine-related Cancer·Adrian F DalyAlbert Beckers
May 3, 2011·Trends in Endocrinology and Metabolism : TEM·Hippokratis KiarisAndrew V Schally
Feb 5, 2015·Cell Cycle·Andrew V SchallyFerenc G Rick
Jul 15, 2015·General and Comparative Endocrinology·Robert W LeaSteve Harvey

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.